The Therapeutic Strategies Targeting Mitochondrial Metabolism in Cardiovascular DiseaseXiaoyang Huang, Xiaoyong Tong, Zhenhua Zeng et al.|Pharmaceutics|2022Cited by 22
Substitution of SERCA2 Cys674 aggravates cardiac fibrosis by promoting the transformation of cardiac fibroblasts to cardiac myofibroblastsXiaoyang Huang, Xiaoyong Tong, Xiaojuan Lin et al.|Biochemical Pharmacology|2022Cited by 12
CDN1163 alleviates SERCA2 dysfunction-induced pulmonary vascular remodeling by inhibiting the phenotypic transition of pulmonary artery smooth muscle cellsWeimin Yu, Xiaoyong Tong, Qian Zhang et al.|Clinical and Experimental Hypertension|2023Cited by 9